Retatrutide
RETA
Retatrutide is a next-generation triple-receptor agonist targeting GLP-1, GIP, and glucagon receptors. It has demonstrated significant potential in metabolic research, with preclinical studies suggesting it may modulate multiple metabolic pathways simultaneously. Published research has explored its role in energy homeostasis, glucose regulation, and body composition changes in research models.
Certificates of Analysis (COAs) are available upon request. Contact support@nexaralabsusa.com for COA documentation.
For research use only. Not for human consumption.
Research Applications
- Metabolic pathway modulation and triple-receptor agonism studies
- Body composition and energy expenditure research in preclinical models
- Glucose homeostasis and insulin signaling pathway analysis
- Appetite signaling and satiety pathway investigation
- Comparative efficacy studies against single and dual agonists
What's Included
- 1x lyophilized vial (10mg)
- Certificate of Analysis (COA)
- Proper storage instructions
Testing & Verification
- HPLC purity analysis
- Mass spectrometry identification
- Endotoxin (LAL) testing
- Sterility verification
For research use only. Not for human consumption.
These products are not intended to diagnose, treat, cure, or prevent any disease. They are sold strictly as research chemicals for laboratory use.
Preorder: All orders are currently preorders. Expected fulfillment within 6 weeks. You will receive tracking information once your order ships.